Literature DB >> 30151503

Distinct neuroimaging features define Parkinson's disease and welding-related neurotoxicity.

Eun-Young Lee1, Mechelle M Lewis1,2, Richard B Mailman1,2, Xuemei Huang1,2,3,4,5.   

Abstract

Entities:  

Year:  2017        PMID： 30151503      PMCID： PMC6108171     

Source DB:  PubMed          Journal:  Neurologist (Hyderabad)


× No keyword cloud information.
  36 in total

Review 1.  Neuroimaging in Parkinson's disease: from pathology to diagnosis.

Authors:  A Jon Stoessl
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  Correlation of brain magnetic resonance imaging changes with pallidal manganese concentrations in rhesus monkeys following subchronic manganese inhalation.

Authors:  David C Dorman; Melanie F Struve; Brian A Wong; Janice A Dye; Ian D Robertson
Journal:  Toxicol Sci       Date:  2006-04-25       Impact factor: 4.849

3.  Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.

Authors:  Patrice Péran; Andrea Cherubini; Francesca Assogna; Fabrizio Piras; Carlo Quattrocchi; Antonella Peppe; Pierre Celsis; Olivier Rascol; Jean-François Démonet; Alessandro Stefani; Mariangela Pierantozzi; Francesco Ernesto Pontieri; Carlo Caltagirone; Gianfranco Spalletta; Umberto Sabatini
Journal:  Brain       Date:  2010-08-23       Impact factor: 13.501

4.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI.

Authors:  P J Basser; C Pierpaoli
Journal:  J Magn Reson B       Date:  1996-06

5.  Longitudinal changes in free-water within the substantia nigra of Parkinson's disease.

Authors:  Edward Ofori; Ofer Pasternak; Peggy J Planetta; Hong Li; Roxana G Burciu; Amy F Snyder; Song Lai; Michael S Okun; David E Vaillancourt
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

6.  Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates.

Authors:  Tomás R Guilarte; Ming-Kai Chen; Jennifer L McGlothan; Tatyana Verina; Dean F Wong; Yun Zhou; Mohab Alexander; Charles A Rohde; Tore Syversen; Emmanuel Decamp; Amy Jo Koser; Stephanie Fritz; Heather Gonczi; David W Anderson; Jay S Schneider
Journal:  Exp Neurol       Date:  2006-08-22       Impact factor: 5.330

Review 7.  Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA.

Authors:  S Fahn
Journal:  Arch Neurol       Date:  1999-05

Review 8.  Imaging neurodegeneration in Parkinson's disease.

Authors:  Nicola Pavese; David J Brooks
Journal:  Biochim Biophys Acta       Date:  2008-10-17

9.  Increased R2* in the Caudate Nucleus of Asymptomatic Welders.

Authors:  Eun-Young Lee; Michael R Flynn; Guangwei Du; Yunqing Li; Mechelle M Lewis; Amy H Herring; Eric Van Buren; Scott Van Buren; Lan Kong; Rebecca C Fry; Amanda M Snyder; James R Connor; Qing X Yang; Richard B Mailman; Xuemei Huang
Journal:  Toxicol Sci       Date:  2016-01-14       Impact factor: 4.849

Review 10.  Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features.

Authors:  Gunnar F Kwakye; Monica M B Paoliello; Somshuvra Mukhopadhyay; Aaron B Bowman; Michael Aschner
Journal:  Int J Environ Res Public Health       Date:  2015-07-06       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.